MyAverix Finance
F · Healthcare
EYEPOINT PHARMAC. DL-01 (PV3B)
Biotechnology
EYEPOINT PHARMAC. DL-01 (PV3B) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $892.10M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PV3B
EYEPOINT PHARMAC. DL-01 (PV3B) — FAQ
What is EYEPOINT PHARMAC. DL-01's market cap?
EYEPOINT PHARMAC. DL-01 (PV3B) has a reported market cap of $892.10M (data as of 2026-03-30).
What is PV3B's P/E ratio?
The price-to-earnings (P/E) ratio for EYEPOINT PHARMAC. DL-01 (PV3B) is 18.00 (data as of 2026-03-30).
Does EYEPOINT PHARMAC. DL-01 pay a dividend?
Dividend yield is not available in the current snapshot for EYEPOINT PHARMAC. DL-01 (PV3B). Check the MyAverix Finance app for the latest dividend data.
What sector is EYEPOINT PHARMAC. DL-01 in?
EYEPOINT PHARMAC. DL-01 (PV3B) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PV3B listed on?
PV3B is listed on F.
What is EYEPOINT PHARMAC. DL-01's net margin?
EYEPOINT PHARMAC. DL-01 (PV3B) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.